Anya Biopharm (ROCO:7776) Notes Receivable: NT$0.00 Mil (As of Dec. 2025)


ROCO:7776 Anya Biopharm Inc ROCO:7776
12 GF Score
Price NT$31.80
! 4 Warning Signs
View Full Analysis

What is Anya Biopharm Notes Receivable?

Anya Biopharm ROCO:7776 12 Notes Receivable is NT$0.00 Mil as of Dec. 2025. GuruFocus rates ROCO:7776 with a GF Score™ of 12/100. The stock has 4 warning signs investors should review.

Anya Biopharm's Notes Receivable for the quarter that ended in Dec. 2025 was NT$0.00 Mil.

Anya Biopharm Notes Receivable Historical Data

* Premium members only.

The historical data trend for Anya Biopharm's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Anya Biopharm Notes Receivable Chart

Anya Biopharm Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Notes Receivable
0.00 0.00 0.00 0.00

Anya Biopharm Semi-Annual Data
Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Notes Receivable Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
ROCO:7776
12GF Score
Anya Biopharm Inc ROCO:7776
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Anya Biopharm Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of NT$0.00 Mil mean?
Anya Biopharm (ROCO:7776) has a Notes Receivable of NT$0.00 Mil as of Dec. 2025. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Anya Biopharm and its competitors.
Is Anya Biopharm's Notes Receivable too high?
Anya Biopharm's current Notes Receivable is NT$0.00 Mil. Overall, Anya Biopharm has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Anya Biopharm's Notes Receivable compare to VRTX and REGN?
Anya Biopharm's Notes Receivable of NT$0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Biotechnology company?
A good Notes Receivable depends on the Biotechnology industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Anya Biopharm and its competitors. Anya Biopharm's current Notes Receivable is NT$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Anya Biopharm stock overvalued right now?
Anya Biopharm (ROCO:7776) has a current Notes Receivable of NT$0.00 Mil. The current Notes Receivable is NT$0.00 Mil. Anya Biopharm's overall GF Score™ is 12/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Anya Biopharm (ROCO:7776), the current Notes Receivable is NT$0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Anya Biopharm Business Description

Address No. 3-2, Yuanqu Street, 4th Floor, Nangang, Taipei, TWN, 115603
Anya Biopharm Inc is a pharmaceutical company engaged in the Oral Delivery of Peptides. Its patented technology platform Mira/Je is a flexible solution easy to adapt to a large variety of peptides.
12GF Score

Get the complete analysis for ROCO:7776

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$31.80
Price